Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis
Molecular Pharmacology · 2024
DOI: 10.1124/molpharm.123.000779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2024. Verfasst von Yadira X Perez-Paramo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanaly…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington Universi…
Zitieren
APA
Perez-Paramo, Y. X., Dufield, D., Veeramachaneni, R., Parkhurst, E., Harp, C., Ramesh, A., Winger, R. C., Cross, A. H., Gelfand, J. M., Bar-Or, A., Mathews, W. R., & Anania, V. G. (2024). Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis. Molecular Pharmacology. https://doi.org/10.1124/molpharm.123.000779
Vancouver
Perez-Paramo YX, Dufield D, Veeramachaneni R, Parkhurst E, Harp C, Ramesh A, et al. Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis. Molecular Pharmacology. 2024. doi:10.1124/molpharm.123.000779
BibTeX
@article{PerezParamo2024,
author = {Perez-Paramo, Yadira X and Dufield, Dawn and Veeramachaneni, Rathna and Parkhurst, Emily and Harp, Christopher and Ramesh, Akshaya and Winger, Ryan C and Cross, Anne H and Gelfand, Jeffrey M and Bar-Or, Amit and Mathews, W Rodney and Anania, Veronica G},
title = {Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis},
journal = {Molecular Pharmacology},
year = {2024},
doi = {10.1124/molpharm.123.000779}
}
EUVIMED